Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $455,843 | 17 | 98.6% |
| Travel and Lodging | $6,364 | 14 | 1.4% |
| Food and Beverage | $52.68 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Agilent Technologies, Inc. | $402,766 | 3 | $0 (2018) |
| Amgen Inc. | $57,995 | 22 | $0 (2023) |
| AbbVie, Inc. | $1,467 | 8 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $31.13 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.13 | 1 | AstraZeneca Pharmaceuticals LP ($31.13) |
| 2023 | $2,800 | 1 | Amgen Inc. ($2,800) |
| 2022 | $18,900 | 2 | Amgen Inc. ($18,900) |
| 2021 | $4,200 | 1 | Amgen Inc. ($4,200) |
| 2020 | $5,750 | 2 | Amgen Inc. ($5,750) |
| 2019 | $26,345 | 16 | Amgen Inc. ($26,345) |
| 2018 | $142,000 | 9 | Agilent Technologies, Inc. ($140,533) |
| 2017 | $262,233 | 2 | Agilent Technologies, Inc. ($262,233) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 07/20/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $10,500.00 | General |
| 04/22/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $8,400.00 | General |
| 08/20/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| 12/02/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $3,625.00 | General |
| 05/06/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| 11/08/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,875.00 | General |
| 11/08/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 09/25/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $7.23 | General |
| 07/26/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 07/26/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 04/09/2019 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $44.80 | General |
| 04/05/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $5,375.00 | General |
| 04/05/2019 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $194.72 | General |
| 02/27/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $163.02 | General |
| 02/25/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $247.95 | General |
| 02/18/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $221.00 | General |
| 02/18/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $216.30 | General |
| 02/14/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 02/14/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 02/14/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 02/14/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 09/25/2018 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $126.00 | General |
| 09/25/2018 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $124.58 | General |
About Dr. Holly Dasghaib, MD
Dr. Holly Dasghaib, MD is a Cytopathology healthcare provider based in Del Mar, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003876038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Holly Dasghaib, MD has received a total of $462,260 in payments from pharmaceutical and medical device companies, with $31.13 received in 2024. These payments were reported across 34 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($455,843).
Practice Information
- Specialty Cytopathology
- Other Specialties Hematology, Anatomic Pathology & Clinical Pathology
- Location Del Mar, CA
- Active Since 03/24/2006
- Last Updated 02/09/2022
- Taxonomy Code 207ZC0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003876038
Products in Payments
- ENHERTU (Biological) $31.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.